MCF-12F (ATCC® CRL-10783)

Organism: Homo sapiens, human  /  Cell Type: Epithelial  /  Tissue: mammary gland; breast  /  Disease: normal

Organism Homo sapiens, human
Tissue mammary gland; breast
Cell Type Epithelial
Product Format frozen
Morphology epithelial
Culture Properties adherent
Biosafety Level 1
Disease normal
Age 60 years
Gender female
Ethnicity Caucasian
Storage Conditions liquid nitrogen vapor phase
Karyotype aneuploid
Derivation

The MCF-12F cell line is a non-tumorigenic epithelial cell line established from tissue taken ateduction mammoplasty from a nulliparous patient with fibrocystic breast disease that contained focal areas of intraductal hyperplasia.

The line was produced by long term culture in serum free medium with low Ca++ concentration.

MCF-12F was derived from floating cells in the population.

Cells derived from an adherent population are available (see MCF-12A, ATCC CRL-10782).

Antigen Expression
Blood Type B, RH +
Genes Expressed
epithelial mucin; sialomucin; milk fat globule membrane antigen
Cellular Products
epithelial mucin; sialomucin; milk fat globule membrane antigen
Tumorigenic No
Effects
No, in immunosuppressed mice
Yes, in semisolid medium
Comments

The cells are positive for epithelial cytokeratins 8, 14 and 18, and negative for cytokeratin 19.

They exhibit typical luminal epithelial morphology, three dimensional growth in collagen, and form domes in confluent cultures.

Complete Growth Medium Base medium: Combine 14.8g/L Dulbecco's modified Eagle's medium and Ham's F12 base (Sigma, D-9785), 1.2g NaHCO3 (Sigma, S-5761), 0.365g L-glutamine (Sigma, G-3126), 0.059g L-leucine (Sigma, L-8912), 0.0912g L-lysine (Sigma, L-8662), 0.017g L-methionine (Sigma, M-5308), 0.0612g MgCl2.6H2O (Sigma, M-1028), 0.0488g MgSO4.7H2O (Sigma, M-3409), 0.006g CaCl2.2H2O (Sigma, C-8106), and 0.0086g Phenol Red (Sigma, P-3532). Fill to 1L with Ultrapure Cell Grade water (ATCC® 30-2205). Stir to dissolve. Adjust pH to 7.1 – 7.3. Filter-sterilize using a 0.22 µm filter. Complete growth medium: Combine base medium with 20 ng/mL epidermal growth factor (Sigma, E-9644), 100 ng/mL cholera toxin (Sigma, C-8052), 0.01 mg/mL human insulin (Sigma, I-2643), 500 ng/mL hydrocortisone (Sigma, H-0888), and 5% Chelex-treated horse serum.
Subculturing Volumes used in this protocol are for 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
  1. Remove and discard culture medium.
  2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
  3. Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
    Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.
  4. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
  5. To remove trypsin-EDTA solution, transfer cell suspension to centrifuge tube and spin at approximately 125 x g for 5 to 10 minutes. Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels.
  6. Incubate cultures at 37°C.
Subcultivation Ratio: A subcultivation ratio of 1:2 is recommended
Medium Renewal: Every 2 to 3 days

Note: For more information on enzymatic dissociation and subculturing of cell lines consult Chapter 10 in Culture of Animal Cells, a manual of Basic Technique by R. Ian Freshney, 3rd edition, published by Alan R. Liss, N.Y., 1994.

Cryopreservation Complete growth medium supplemented with 5% (v/v) DMSO. Cell culture tested DMSO is available as ATCC Catalog No. 4-X.

Culture Conditions
Temperature: 37°C
STR Profile
Amelogenin: X
CSF1PO: 10,11
D13S317: 9,11
D16S539: 9,12
D5S818: 11,13
D7S820: 8,11
THO1: 7
TPOX: 8
vWA: 18
Isoenzymes
AK-1, 1
ES-D, 1
G6PD, B
GLO-I, 1-2
PGM1, 1
PGM3, 1
Population Doubling Time 20 hrs
Name of Depositor Michigan Cancer Foundation
References

Pauley RJ, et al. Immortal human mammary epithelial cell sublines. US Patent 5,206,165 dated Apr 27 1993

Paine TM, et al. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int. J. Cancer 50: 463-473, 1992. PubMed: 1370949

Hoppe HC, et al. Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells. Infect. Immun. 65: 3896-3905, 1997. PubMed: 9284169

Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.

Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.

Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.

Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online at http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm

Basic Documentation
FAQ's
  1. Protocol for making Chelex-treated serum


    Date Updated: 4/4/2014

References

Pauley RJ, et al. Immortal human mammary epithelial cell sublines. US Patent 5,206,165 dated Apr 27 1993

Paine TM, et al. Characterization of epithelial phenotypes in mortal and immortal human breast cells. Int. J. Cancer 50: 463-473, 1992. PubMed: 1370949

Hoppe HC, et al. Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells. Infect. Immun. 65: 3896-3905, 1997. PubMed: 9284169

Hay, R. J., Caputo, J. L., and Macy, M. L., Eds. (1992), ATCC Quality Control Methods for Cell Lines. 2nd edition, Published by ATCC.

Caputo, J. L., Biosafety procedures in cell culture. J. Tissue Culture Methods 11:223-227, 1988.

Fleming, D.O., Richardson, J. H., Tulis, J.J. and Vesley, D., (1995) Laboratory Safety: Principles and Practice. Second edition, ASM press, Washington, DC.

Biosafety in Microbiological and Biomedical Laboratories, 5th ed. HHS. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online at http://www.cdc.gov/OD/ohs/biosfty/bmbl5/bmbl5toc.htm